Onsite Hypochlorous Acid in Hospitals: Cutting Disinfection Cost Without Compromising Compliance. Cost, the evidence, contract pricing for hospital groups, and the compliance guardrails. October 2026, revision 1.
Written for hospital leadership, infection prevention and environmental services. It treats disinfection cost as a waste problem first — overlapping products, mis-dilution, unproductive labor and rework — and works through the compliance guardrails, the evidence and the numbers from there.
What is inside
| Section | What it covers |
|---|---|
| 1. What this paper claims, and what it does not | The device position, where documented claims come from, and how each cost figure is sourced. |
| 2. Executive summary | Five cost levers, and the hospital-group contract case in one paragraph. |
| 3. Where disinfection money goes | Labor, products, wipes and rework; the evidence on cleaning thoroughness, and what a hospital-onset C. difficile case costs. |
| 4. What a generator is | The device position, and the two failure modes onsite generation removes: running out and mis-diluting. |
| 5. The research on hypochlorous acid | Microbac Laboratories testing against murine norovirus MNV-G at 50 ppm, one minute, at pH 5 and pH 8, with the conditions and the limits stated. |
| 6. Where documented claims come from | HOCl-AS200, EPA Reg. No. 101112-1: 21 organisms at a five-minute contact time. C. difficile spores are not on the label. |
| 7. The compliance guardrails | EPA label and List K, Spaulding, CDC guidance, CMS §482.42, The Joint Commission, OSHA and device IFUs, and what each means for cost reduction. |
| 8. The five cost levers | Product rationalization, onsite generation, workflow and labor, targeted technology, and reusables, with modeled ranges and the compliance check for each. |
| 9. Cost analysis and contract pricing | The E-300 and HOCl-AS200 against a published 250-bed hospital estimate; contract pricing for hospital groups at $5.95 a gallon in 275-gallon totes; break-even by registered share. |
| 10. Proving compliance while costs fall | Fluorescent marker and ATP audits, contact-time adherence, dilution checks and outcome surveillance, with a stop rule. |
| 11. Implementation roadmap | Four phases over twelve months, each gated by infection prevention sign-off. |
| 12. What it does not fix | Precleaning, spores, labor discipline, equipment and supply, device compatibility, and infection outcomes; plus eight questions to ask any supplier, including us. |
What this paper claims, and what it does not
The cover of the paper carries this in full. In short: an EcoloxTech system is a device that produces a hypochlorous acid solution on site, it is regulated by the EPA as a device, and we make no efficacy claims for it or for the solution it produces. Laboratory and published findings are reported as findings about hypochlorous acid under the conditions stated, attributed to the laboratory that produced them. Documented disinfection claims come from HOCl-AS200 (EPA Reg. No. 101112-1) used according to its label. Cost figures are labelled by source: EcoloxTech list and contract prices, a published estimate of hospital spend, and an illustrative model. We do not claim that our equipment prevents healthcare-associated infections.
Related reading
The sector programme is at healthcare and senior care, with companion pages on compliance and audits and ROI and savings. The registered product is HOCl-AS200, and the generator in the cost analysis is the EcoloxTech 300.